KATY BOREN: Open Payments
NPI 1740891225 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 53 payments from 14 companies in 2025. Trend: 2023 $613 · 2024 $1,193 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $180 |
| ABBVIE INC. | 10 | $157 |
| Incyte Corporation | 3 | $153 |
| Janssen Biotech, Inc. | 11 | $151 |
| PFIZER INC. | 4 | $149 |
| Journey Medical Corporation | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Organon LLC | 5 | $61 |
| Amgen Inc. | 3 | $60 |
| Galderma Laboratories, L.P. | 2 | $37 |
Products named: Opzelura, TREMFYA, CIBINQO, EBGLYSS, RINVOQ, TALTZ, SKYRIZI, OTEZLA.
Industry payments across TX — which companies pay providers there.
